CD33 and acute myeloid leukemia: Importantly, CD123 has been reported in CD34 + CD38-Lin- populations from healthy bone marrow (BM) and cord blood (CB) donors, with intensities of expression significantly lower than their AML counterparts (such differences were not observed for other myeloid markers such as CD13 and CD33)14.